Literature DB >> 24171201

Reply to Crispin et al.: Molecular model that accounts for the biological and physical properties of sialylated Fc.

Peter Sondermann, Andrew Pincetic, Jad Maamary, Katja Lammens, Jeffrey V Ravetch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24171201      PMCID： PMC3780839          DOI： 10.1073/pnas.1311721110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  6 in total

1.  Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.

Authors:  Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2006-08-04       Impact factor: 47.728

2.  Crystal structure of sialylated IgG Fc: implications for the mechanism of intravenous immunoglobulin therapy.

Authors:  Max Crispin; Xiaojie Yu; Thomas A Bowden
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-08       Impact factor: 11.205

3.  Revisiting the role of glycosylation in the structure of human IgG Fc.

Authors:  M Jack Borrok; Sang Taek Jung; Tae Hyun Kang; Arthur F Monzingo; George Georgiou
Journal:  ACS Chem Biol       Date:  2012-07-10       Impact factor: 5.100

4.  General mechanism for modulating immunoglobulin effector function.

Authors:  Peter Sondermann; Andrew Pincetic; Jad Maamary; Katja Lammens; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-22       Impact factor: 11.205

5.  Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity.

Authors:  S Krapp; Y Mimura; R Jefferis; R Huber; P Sondermann
Journal:  J Mol Biol       Date:  2003-01-31       Impact factor: 5.469

6.  NMR characterization of immunoglobulin G Fc glycan motion on enzymatic sialylation.

Authors:  Adam W Barb; Lu Meng; Zhongwei Gao; Roy W Johnson; Kelley W Moremen; James H Prestegard
Journal:  Biochemistry       Date:  2012-05-22       Impact factor: 3.162
  6 in total
  5 in total

1.  Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils.

Authors:  Ian K Campbell; Sylvia Miescher; Donald R Branch; Patrick J Mott; Alan H Lazarus; Dongji Han; Eugene Maraskovsky; Adrian W Zuercher; Anton Neschadim; Danila Leontyev; Brent S McKenzie; Fabian Käsermann
Journal:  J Immunol       Date:  2014-04-23       Impact factor: 5.422

2.  Role of sialylation in the anti-inflammatory activity of intravenous immunoglobulin - F(ab')₂ versus Fc sialylation.

Authors:  I Schwab; F Nimmerjahn
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

Review 3.  A perspective on the structure and receptor binding properties of immunoglobulin G Fc.

Authors:  Quinlin M Hanson; Adam W Barb
Journal:  Biochemistry       Date:  2015-05-07       Impact factor: 3.162

Review 4.  Differences in Anti-Inflammatory Actions of Intravenous Immunoglobulin between Mice and Men: More than Meets the Eye.

Authors:  Angela S W Tjon; Rogier van Gent; Teunis B Geijtenbeek; Jaap Kwekkeboom
Journal:  Front Immunol       Date:  2015-04-28       Impact factor: 7.561

Review 5.  Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies.

Authors:  Ngoc Phuong Lan Le; Thomas A Bowden; Weston B Struwe; Max Crispin
Journal:  Biochim Biophys Acta       Date:  2016-04-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.